Topic:Atherosclerosis
Atherosclerosis in horses refers to the pathological process characterized by the accumulation of lipids, cholesterol, and other substances in the arterial walls, leading to the formation of plaques. This condition can result in the narrowing and hardening of arteries, potentially impacting blood flow and cardiovascular function. Although atherosclerosis is well-documented in humans, its occurrence and implications in equine species are less commonly reported. Research in this area often focuses on understanding the incidence, pathophysiology, and potential risk factors associated with atherosclerosis in horses. This page compiles peer-reviewed research studies and scholarly articles that investigate the prevalence, underlying mechanisms, and clinical outcomes of atherosclerosis in equine health.
Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses. In addition to its role as an energy storage depot, adipose tissue is now recognized as a complex endocrine organ. Adipose tissue releases a variety of factors, termed adipokines, that regulate energy metabolism, cardiovascular function, reproductive status, and immune function. Some of the better-studied adipokines include leptin, adiponectin, and components of the renin-angiotensin system such as angiotensinogen. The function of more recently discovered adipokines such as resistin are under intense scrutiny. Abnormal production or regulation of adipokines occurs in obese individuals and is i...
[Fat and content of yakutan horse fat tissue]. The gas chromatography method the fat acid content of the young Yakut horse meat fat tissue lipids was studied in relation to the age group, various parts of the body and anatomic topographic location of the fat/It was determined that the of sixth-month young horse is the source of the PUFA omega-3 that allows to recommend horse meat as a dietary product for atherosclerosis prevention. By medial chain fat content the lipids of the 6 month young horses are close to the lipids of milk fat.
Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. The effects of dietary soy isoflavones (IF) and conjugated equine estrogens (CEE) on circulating inflammatory markers were determined at the end of a 3-yr study of ovariectomized monkeys consuming a moderately atherogenic diet. Treatments were: 1) control, receiving alcohol-extracted soy-protein-based diet with low IF content (comparable to approximately 5 mg/d); 2) CEE, added to the control diet at a dose comparable to 0.625 mg/d; and 3) IF, consumed as a part of unextracted soy protein isolate at a dose comparable to 129 mg/d. Serum soluble vascular cell adhesion molecule-1 (sVCAM-1) was red...
The new conundrum: do estrogens have any cardiovascular benefits? Clearly, a new era has begun, with increasing numbers of the scientific/medical community asking whether estrogens have any cardiovascular benefits. Doubts have arisen from two randomized prospective trials. The Heart and Estrogen/progestin Replacement Study (women who were generally beyond 65 years of age with preexisting coronary heart disease) found no benefit in reducing coronary events by a combination of estrogens and a progestin. Later, the Estrogen Replacement Atherosclerosis Trial reported that no benefit could be shown for either conjugated equine estrogens only or the combined thera...
Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Although estrogen replacement therapy is associated with reduced risk of coronary heart disease and reduced extent of coronary artery atherosclerosis, the effects of combined (estrogen plus progestin) hormone-replacement therapy are uncertain. Some observational data indicate that users of combined hormone replacement consisting of continuously administered oral conjugated equine estrogens (CEE) and oral sequentially administered (7 to 14 days per month) medroxyprogesterone acetate (MPA) experience a reduction in risk similar to that of users of CEE alone. However, the effects of combined, con...
Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. We attempted to determine whether continuous and cyclic medroxyprogesterone acetate modulates the effects of estrogen on dilation of atherosclerotic coronary arteries in surgically postmenopausal female monkeys. Background: Estrogen replacement in postmenopausal women preserves normal dilator responses of atherosclerotic coronary arteries. The effects of progestins on coronary artery reactivity have not been determined. Methods: Repeated quantitative coronary angiography was used to study the effects after 1 month of 1) no hormone replacement (control) or oral administration of 2) continuous c...